Munehiro Kitada, Yoshio Ogura, Kayo Yamamoto, Kazunori Konishi, Akihiko Nakagawa, Atsushi Nakagawa, Dasiuke Koya. Efficacy of SGLT2 inhibitor in type 2 diabetic patients under dietary instructions: A pilot study. Clinical and Medical Investigations. 2020. 5. 3. 1-8
2010/07 - Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects. Diabetes Research and Clinical Practice. 85:171-178, 2009.
2010/07 - 金沢医科大学医学会 金沢医科大学医学会「論文表彰」 Carotid atherosclerosis mediated by visceral adiposity and adipocytokines in type 2 diabetic subjects. Diabetes Research and Clinical Practice. 85:171-178, 2009.
2009/07 - AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects.Diabetes Rescarch and Clinical Practice 81: 310-315, 2008.
2009/07 - 金沢医科大学医学会 金沢医科大学医学会「論文表彰」 AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects.Diabetes Rescarch and Clinical Practice 81: 310-315, 2008.